A multi-center, double-blind, randomized, placebo-controlled trial protocol to assess Traumeel injection vs dexamethasone injection in rotator cuff syndrome: the TRAumeel in ROtator cuff syndrome (TRARO) study protocol

Luc Vanden Bossche, Guy Vanderstraeten, Luc Vanden Bossche, Guy Vanderstraeten

Abstract

Background: Shoulder pain is a common musculoskeletal symptom with a wide range of potential causes; however, the majority of conditions can be managed with conservative treatment. The aim of this study is to assess the efficacy and safety of Traumeel injections versus corticosteroid injections and placebo in the treatment of rotator cuff syndrome and bursitis and expand the current evidence base for the conservative treatment of rotator cuff syndrome.

Methods/design: This is a multi-center, randomized, double-blind, 16-week, three-arm, parallel-group, active- and placebo-controlled trial to assess the efficacy and safety of Traumeel 2 ml injection versus dexamethasone 8 mg injection versus placebo (saline solution). Patients will be randomly allocated to Traumeel, dexamethasone or placebo in a 2:2:1 randomization. After 1 week screening, patients will receive 3 injections at weekly intervals (days 1, 8 and 15) with additional follow-up assessments on day 22, a telephone consultation in week 9 and a final visit at week 15. Male and female patients aged 40 to 65 years, inclusive, will be recruited if they have acute episodes of chronic rotator cuff syndrome and/or bursitis. Patients with calcifications in the shoulder joint or a complete rotator cuff tear will be excluded. At least 160 patients will be recruited. All subacromial injections will be performed under ultrasound guidance utilizing a common technique. The only rescue medication permitted will be paracetamol (acetaminophen), with usage recorded. The primary endpoint is change from baseline in abduction-rotation pain visual analog scale (0-100 mm scale, 0 corresponds to no pain and 100 to extreme pain) at day 22 (Traumeel injections versus dexamethasone injections) for active external rotation. Secondary efficacy parameters include range of motion, disability of arm, shoulder, hand score and patient's/investigator's global assessment. Clinical efficacy will be assessed as non-inferiority of Traumeel with respect to dexamethasone regarding the primary efficacy parameter.

Discussion: It is hoped that the results of this trial will expand the treatment options and evidence base available for the management of rotator cuff disease.

Trial registration: ClinicalTrials.gov: NCT01702233 . EudraCT number: 2012-003393-12.

Figures

Figure 1
Figure 1
Patient flow through the study.

References

    1. Rekola KE, Keinanen-Kiukaanniemi S, Takala J. Use of primary health services in sparsely populated country districts by patients with musculoskeletal symptoms: consultations with a physician. J Epidemiol Community Health. 1993;47:153–7. doi: 10.1136/jech.47.2.153.
    1. Gomoll AH, Katz JN, Warner JP, Millett PJ. Rotator cuff disorders. Recognition and management among patients with shoulder pain. Arthritis Rheum. 2004;50:3751–61. doi: 10.1002/art.20668.
    1. Praemer A, Furner S, Rice D. Musculoskeletal conditions in the United States. 2. Rosemont, IL: American Academy of Orthopaedic Surgeons; 1999.
    1. Goldberg BA, Nowinski RJ, Matsen FA., 3rd Outcome of nonoperative management of full thickness rotator cuff tears. Clin Orthop Relat Res. 2001;382:99–107. doi: 10.1097/00003086-200101000-00015.
    1. Varthi A, Piposar J, Chan W, Blaine TA. Upper extremity: biologic treatments for shoulder pain. Curr Orthop Pract. 2013;24:360–4. doi: 10.1097/BCO.0b013e31829a8d5b.
    1. Coghlan JA, Buchbinder R, Green R, Johnston RV, Bell SN. Surgery for rotator cuff disease. Cochrane Database Syst Rev. 2008;1:CD005619.
    1. Galatz LM, Griggs S, Cameron BD, Iannotti JP. Prospective longitudinal analysis of postoperative shoulder function: a ten-year follow-up study of full-thickness rotator cuff tears. J Bone Joint Surg Am. 2001;83:982–9.
    1. Buchbinder R, Green S, Youd JM. Corticosteroid injections for shoulder pain. Cochrane Database Syst Rev. 2003;1:CD004016.
    1. Arroll B, Goodyear-Smith F. Corticosteroid injections for painful shoulder: a meta-analysis. Br J Gen Pract. 2005;55:224–8.
    1. Henkus H-E, Cobben LPJ, Coerkamp EG, Nelissen RGHH, van Arkel ERA. The accuracy of subacromial injections: a prospective randomized magnetic resonance imaging study. J Arthrosc Relat Surg. 2006;22:277–82. doi: 10.1016/j.arthro.2005.12.019.
    1. Marder RA, Kim SH, Labson JD, Hunter JC. Injection of the subacromial bursa in patients with rotator cuff syndrome: a prospective, randomized study comparing the effectiveness of different routes. J Bone Joint Surg Am. 2012;94:1442–7. doi: 10.2106/JBJS.K.00534.
    1. Cesnulevicius K. The bioregulatory approach to work-related musculoskeletal disorders: using the multicomponent ultra low-dose medication Traumeel to target the multiple pathophysiological processes of the disease. Altern Ther Health Med. 2011;17(Suppl 2):S8–17.
    1. Lussignoli S, Bertani S, Metelmann H, Bellavite P, Conforti A. Effect of Traumeel S®, a homeopathic formulation, on blood-induced inflammation in rats. Complement Ther Med. 1999;7:225–30. doi: 10.1016/S0965-2299(99)80006-5.
    1. Thiel W. The treatment of recent traumatic blood effusions of the knee joint. Biol Ther. 1994;XII:242–8.
    1. Birnesser H, Oberbaum M, Klein P, Weiser M. The homeopathic preparation Traumeel compared with NSAIDs for symptomatic treatment of epicondylitis. J Musculoskel Res. 2004;2(3):119–28. doi: 10.1142/S0218957704001284.
    1. Schneider C, Schneider B, Hanisch J, van Haselen R. The role of a homoeopathic preparation compared with conventional therapy in the treatment of injuries: an observational cohort study. Complement Ther Med. 2008;16:22–7. doi: 10.1016/j.ctim.2007.04.004.
    1. Article 1(5) of Directive 2001/83/EC as amended by 2004/27/EC []
    1. Moen MH, De Vos RJ, van Arkel ERA, Weir A, Moussavi J, Kraan T, et al. De meest waardevolle klinische schoudertesten, een literatuuroverzicht. Sport Geneesk. 2008;4:1–14.
    1. Woodward TW, Best TM. The painful shoulder. Part I clinical evaluation. Am Fam Physician. 2000;61:3079–88.
    1. Stephens MB, Beutler AI, O’Connor FG. Musculoskeletal injections: a review of the evidence. Am Fam Physician. 2008;78:971–6.
    1. Plafki C, Steffen R, Willburger RE, Wittenberg RH. Local anaesthetic injection with and without corticosteroids for subacromial impingement syndrome. Int Orthop. 2000;24:40–2. doi: 10.1007/s002640050010.
    1. Shibata Y, Midorikawa K, Emoto G, Naito M. Clinical evaluation of sodium hyaluronate for the treatment of patients with rotator cuff tear. J Shoulder Elbow Surg. 2001;10:209–16. doi: 10.1067/mse.2001.113501.
    1. Tillander B, Franzen LE, Karlsson MH, Norlin R. Effect of steroid injections on the rotator cuff: an experimental study in rats. J Shoulder Elbow Surg. 1999;8:271–4. doi: 10.1016/S1058-2746(99)90141-6.
    1. Wei AS, Callaci JJ, Juknells D, Marra G, Tonino P, Freedman KB, et al. The effect of corticosteroid on collagen expression in injured rotator cuff tendon. J Bone Joint Surg Am. 2006;88:1331–8. doi: 10.2106/JBJS.E.00806.
    1. Lee HJ, Kim YS, Ok JH, Lee YK, Ha MY. Effect of a single subacromial prednisolone injection in acute rotator cuff tears in a rat model. Knee Surg Sports Traumatol Arthrosc 2013, Jan 31 epub ahead of print.
    1. Bhatia M, Singh B, Nicolaou N, Ravikumar KJ. Correlation between rotator cuff tears and repeated subacromial steroid injections: a case-controlled study. Ann R Coll Surg Engl. 2009;91:414–6. doi: 10.1308/003588409X428261.
    1. American Academy of Orthopaedic Surgeons . Optimizing the management of rotator cuff problems. Guideline and evidence report. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2010.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi